SensAgain
Restoring of SENSAtions from Lost LeGs for health And qualIty of life augmeNtation in amputees
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SensAgain project word cloud
Explore the words cloud of the SensAgain project. It provides you a very rough idea of what is the project "SensAgain" about.
Project "SensAgain" data sheet
The following table provides information about the project.
| Coordinator |
SENSARS NEUROPROSTHETICS SARL
Organization address contact info |
| Coordinator Country | Switzerland [CH] |
| Project website | http://www.sensars.com |
| Total cost | 99˙912 € |
| EC max contribution | 99˙912 € (100%) |
| Programme |
1. H2020-EU.1.2.1. (FET Open) |
| Code Call | H2020-FETOPEN-4-2016-2017 |
| Funding Scheme | CSA |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-09-01 to 2019-02-28 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SENSARS NEUROPROSTHETICS SARL | CH (LAUSANNE) | coordinator | 99˙912.00 |
Map
Project objective
During the FET NEBIAS we developed and clinically validated novel and effective restoration of sensory feedback from missing hand in upper-limb amputees. They felt natural sensations, used to ameliorate control and acceptance of prosthesis, and diminish phantom limb pain. The goal of SensAgain is to exploit these results commercially. In particular, we aim at verifying whether the innovation generated during NEBIAS could be used to provide valuable device for lower-limb amputees. We target them because they represent a larger population and suffer health problems related to absence of sensations from prosthesis. Indeed, because of the lack of sensory feedback from available prostheses, they suffer: falls due to unexpected perturbations, asymmetric walking and balance which induce arthritis, osteoporosis and back pain, higher power consumption (with occasional hearth failures), feeling the prosthesis as a foreign body (with consequent abandonment) and phantom pain. The first step we will perform is the validation with market stakeholders, which will enable the identification of the minimum features of a product accepted by the market, and the development of a strategic partnership with manufacturers, which will speed up the realization of a device compliant with CE standards. Then, we will define a clear market penetration strategy. Together with providing disabled persons with a unique device for rehabilitation, SensAgain will boost prosthetic adoption, with the consequent growth of the prosthetics and rehabilitation industries, which at its turn will create new jobs. Finally, by sharing the results with the members of the NEBIAS consortium, we will train academia personnel to structure their research mind-set toward the resolution of problems tailored by the market needs. On the other hand we will favor the process of creating innovation in industry, offering job positions to people with a background in research, in case of success of our translational project.
Deliverables
| Project webpage | Websites, patent fillings, videos etc. | 2019-09-02 11:32:58 |
Take a look to the deliverables list in detail: detailed list of SensAgain deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
Francesco M. Petrini, Alberto Mazzoni†, Jacopo Rigosa†, Federica Giambattistelli, Giuseppe Granata, Beatrice Barra, Alessandra Pampaloni, Eugenio Guglielmelli, Loredana Zollo, Marco Capogrosso, Silvestro Micera†Email author and Stanisa Raspopovic Microneurography as a tool to develop decoding algorithms for peripheral neuro-controlled hand prostheses published pages: , ISSN: 1475-925X, DOI: |
BioMedical Engineering OnLine | 2019-09-02 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENSAGAIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SENSAGAIN" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.1.2.1.)
PANACHE (2020)
Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.
Read More